博士論文

OX40 and LAG3 are associated with better prognosis in advanced gastric cancer patients treated with anti-programmed death-1 antibody

Icons representing 博士論文
The cover of this title could differ from library to library. Link to Help Page

OX40 and LAG3 are associated with better prognosis in advanced gastric cancer patients treated with anti-programmed death-1 antibody

Persistent ID (NDL)
info:ndljp/pid/12071334
Material type
博士論文
Author
大村, 洋文
Publisher
-
Publication date
2021-03-24
Material Format
Digital
Capacity, size, etc.
-
Name of awarding university/degree
九州大学,博士(医学)
View All

Notes on use at the National Diet Library

Notes on use

Note (General):

PubMed番号 : 32203221元資料の権利情報 : (c) The Author(s), under exclusive licence to Cancer Research UK 2020

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Digital

Material Type
博士論文
Author/Editor
大村, 洋文
Publication Date
2021-03-24
Publication Date (W3CDTF)
2021-03-24
Alternative Title
OX40およびLAG3発現は進行胃癌に対する抗PD-1抗体療法の予後良好因子である
Contributor
中山, 敬一
中村, 雅史
馬場, 義裕
Degree grantor/type
九州大学
Date Granted
2021-03-24
Date Granted (W3CDTF)
2021-03-24